Catalent - CTLT Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Catalent in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CTLT shares.
View CTLT analyst ratings or view top-rated stocks.

6 brokers have issued 12-month target prices for Catalent's stock. Their CTLT share price forecasts range from $105.00 to $145.00. On average, they expect the company's share price to reach $122.13 in the next twelve months. This suggests a possible upside of 59.6% from the stock's current price.
View analysts price targets for CTLT or view top-rated stocks among Wall Street analysts.

Catalent's stock was trading at $128.03 at the beginning of the year. Since then, CTLT stock has decreased by 40.2% and is now trading at $76.52.
View the best growth stocks for 2022 here.

Catalent saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 3,650,000 shares, an increase of 11.6% from the August 31st total of 3,270,000 shares. Based on an average daily volume of 1,220,000 shares, the days-to-cover ratio is currently 3.0 days.
View Catalent's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our CTLT earnings forecast.

Catalent, Inc. (NYSE:CTLT) issued its quarterly earnings data on Monday, August, 29th. The company reported $1.19 earnings per share for the quarter, topping the consensus estimate of $1.15 by $0.04. The business earned $1.31 billion during the quarter, compared to analysts' expectations of $1.33 billion. Catalent had a trailing twelve-month return on equity of 14.49% and a net margin of 10.56%. The company's revenue for the quarter was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.08 EPS.
Read the conference call transcript.

Catalent updated its FY 2023 earnings guidance on Tuesday, September, 27th. The company provided EPS guidance of $3.65-$3.99 for the period, compared to the consensus EPS estimate of $4.15. The company issued revenue guidance of $4.97 billion-$5.22 billion, compared to the consensus revenue estimate of $5.26 billion.

391 employees have rated Catalent Chief Executive Officer John R. Chiminski on Glassdoor.com. John R. Chiminski has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Catalent investors own include Abbott Laboratories (ABT), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), NVIDIA (NVDA), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), AT&T (T) and Cisco Systems (CSCO).

Catalent trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTLT."

Shares of CTLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CTLT stock can currently be purchased for approximately $76.52.

Catalent (NYSE:CTLT) has a market capitalization of $13.77 billion and generates $4.83 billion in revenue each year. The company earns $503 million in net income (profit) each year or $2.83 on an earnings per share basis.

The company employs 19,000 workers across the globe.

Catalent's mailing address is 14 SCHOOLHOUSE ROAD, SOMERSET NJ, 08873. The official website for the company is www.catalent.com. The company can be reached via phone at (732) 537-6200, via email at investors@catalent.com, or via fax at 732-537-6480.